We Want to Do Our Part: A Corporate Funder Steps up for Trans Communities

We Want to Do Our Part: A Corporate Funder Steps up for Trans Communities

Transgender communities face inordinate challenges, but receive a small slice of philanthropic funding. With a new grantmaking program that draws on input from the trans community, Gilead Sciences is helping to change that.

Read More

Philanthropic Evolution: A Hotel Mogul Talks Generational Giving

Philanthropic Evolution: A Hotel Mogul Talks Generational Giving

Barry Sternlicht set up a foundation early last decade with his former wife. His adult children now help drive family giving, which includes issues like education reform and diabetes research. Sternlicht talks to us about his journey.

Read More

Why These Health Funders Focus on Care, Rather than Cures, for People with Serious Illness

Why These Health Funders Focus on Care, Rather than Cures, for People with Serious Illness

Most health philanthropy consists of chasing breakthrough cures and treatments. But what many ill people want is improved quality of life—which is why two funders recently launched a campaign to raise awareness of the benefits of palliative care.

Read More

We Are the World’s Second Biggest Foundation. Here’s What Accountability Means to Us

We Are the World’s Second Biggest Foundation. Here’s What Accountability Means to Us

Over the past 18 months, the Wellcome Trust has wrestled with how to respond to growing critiques that philanthropy is at odds with democracy. A top executive at the foundation—which has assets of $30 billion—explains where it came out.

Read More

An Early Corporate Leader in Funding LGBTQ Issues Marches On

An Early Corporate Leader in Funding LGBTQ Issues Marches On

The Levi Strauss Foundation, an early funder in the fight against HIV/AIDS, continues to step up in changing times, meeting a roll-back of hard fought gains in the areas of diversity and inclusion with expanded support for the trans community. 

Read More

Aiming for More Impact, a Key Funder Fighting Heart Attacks is Taking a New Approach

Aiming for More Impact, a Key Funder Fighting Heart Attacks is Taking a New Approach

More than $14 million in recent grants to establish a network of research teams focused on sudden cardiac arrest and heart arrhythmias shows that the American Heart Association is taking on a greater role in setting research priorities.

Read More

With Unique Assets, Health Corporations are Poised to Have a Larger Philanthropic Impact

With Unique Assets, Health Corporations are Poised to Have a Larger Philanthropic Impact

Corporate philanthropy has been changing as more companies align their giving with their mission and get more strategic. A report looks at how this trend is playing out in the health and life sciences industry—and the potential for these firms to have far greater impact.

Read More

As Millions Flow for Campus Research on Health and AI, What Might Be Some Downsides?

As Millions Flow for Campus Research on Health and AI, What Might Be Some Downsides?

The latest installment in the higher ed artificial intelligence gold rush finds a corporate funder backing new research on health and AI. Other campus donors will likely follow, even as some experts warn that this new technology could exacerbate health inequities.

Read More

"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?

"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?

In 2016, the tech billionaire Sean Parker launched the Parker Institute for Cancer Immunotherapy with a $250 million investment. We check in with the institute’s Chief Science Officer to see how things are going and what’s been accomplished so far.

Read More

Filling Critical Gaps: Where Grants for Cancer Research Are Going so Far This Year

Filling Critical Gaps: Where Grants for Cancer Research Are Going so Far This Year

We’ve tracked nearly $80 million in new commitments for cancer research so far this year. With funders keen to leverage limited resources for maximum impact, a majority of that giving has gone to underfunded forms of cancer and young investigators. 

Read More

As Research Yields New Gains, More Money Flows for Genomic Medicine

As Research Yields New Gains, More Money Flows for Genomic Medicine

Using genomics to design far more precise and effective medical treatment plans has been called the “wave of the future.” Now, as breakthroughs increase, more funders are coming to the table to back biomedical research in this emerging field.

Read More

Four Ways Boehringer Ingelheim Funds Health and Science in Connecticut and Beyond

Four Ways Boehringer Ingelheim Funds Health and Science in Connecticut and Beyond

Boehringer Ingelheim and its BI Cares Foundation make a lot of grants in Connecticut, but also to researchers nationwide. What healthcare access, STEM, and research programs does this pharmaceutical giant back?

Read More

New Research for a Lethal Disease: How These Foundations Are Taking on Pancreatic Cancer

New Research for a Lethal Disease: How These Foundations Are Taking on Pancreatic Cancer

Pancreatic cancer often has a grim prognosis, typically evading early detection, and is difficult to treat. Three foundations are determined to change that with research grants for early detection and treatment of the disease.

Read More

“Expedite the Translation.” A Billionaire Keeps the Big Gifts for Medical Research Flowing

“Expedite the Translation.” A Billionaire Keeps the Big Gifts for Medical Research Flowing

A common theme of Len Blavatnik’s giving is an eagerness to support promising areas of medical research. Still, his biggest gift yet—$200 million to Harvard Medical School—has raised the usual questions about big philanthropy.

Read More

To Crack the Puzzles of Alzheimer's, a Foundation Takes a Laser Approach

To Crack the Puzzles of Alzheimer's, a Foundation Takes a Laser Approach

As Alzheimer’s disease inflicts an ever-rising toll on aging populations in the U.S. and overseas, the race is on for research breakthroughs. The Rainwater Charitable Foundation recently announced a major new prize focused on a key protein.

Read More

Medicine's Blind Spot: A Foundation Takes on Diagnostic Error

Medicine's Blind Spot: A Foundation Takes on Diagnostic Error

Diagnostic errors are the most common cause of medical errors, causing an estimated 40,000 to 80,000 deaths per year. But there is little funding for research on this problem. The Gordon and Betty Moore Foundation is looking to change that.

Read More